The anticytokine neuropeptide a-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: Comparisons with other anticytokine molecules

NeuroImmunoModulation

Volumn 1, Issue 5, 1994, Pages 321-328

  Catania, Anna ^a   Gerloni, Valeria ^b   Procaccia, Samuele ^a   Airaghi, Lorena ^a   Manfredi, Maria G ^a   Lomater, Claudia ^b   Grossi, Luca ^a   Lipton, James M ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arthritis, juvenile chronic; Interleukin 1 receptor antagonist; Rheumatoid arthritis; Tumor necrosis factor receptor, soluble; Melanocyte stimulating hormone

Indexed keywords

ALPHA INTERMEDIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ALPHA-MSH; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0028505291     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097183     Document Type: Article

References (38)

1. Hopkins SJ: Cytokines and their significance in rheumatic disease: in Orme M (ed): Anti-Rheumatic Drugs. New York, Pergamon Press, 1990, pp 49-118.
2. Harris ED: Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-1289.
3. Chu CQ, Field M, Feldman M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-1132.
4. Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldman M, Maini RN: Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 1992;31:801-809.
5. Deleuran BW, Chu CQ, Field M, Brennan FM, Mitchell T, Feldman M, Maini RN: Localization of TNF receptors in the synovial tissue and cartilage/pannus junction in rheumatoid arthritis: Implication for local actions of TNF. Arthritis Rheum 1992;35:1170-1178.
6. Saklatvala J: Tumor necrosis factor a stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-549.
7. Bertolini DR, Nedwin GE, Bringman TS, Smith DE, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by tumor necrosis factor. Nature 1986;319:516-518.
8. Dinarello CA, Thompson RC: Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro. Immunol T oday 1991;12:405-410.
9. Arend WP, Wclgus HG, Thompson RC. Eisenberg SP: Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990;85:1694-1697.
10. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaiflcr NJ: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 1992;149:1054-1062.
11. Malyak M, Swaney RE, Arend WP: Levels of synovial fluid interleukin 1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial neutrophils. Arthritis Rheum 1993;36:781-789.
12. Cope AP, Adcrka D, Doherty M. Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M: Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-1169.
13. Engelman H, Novick D, Wallach D: Two tumor necrosis factor-binding proteins purified from human urine. J Biol Chem 1990;265:1531-1536.
14. van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845-4849.
15. Catania A, Lipton JM: α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev 1993;14:564-576.
16. Catania A, Lipton JM: α-MSH peptides in host responses: From basic evidence to human research. Ann N Y Acad Sci 1993;680:412-423.
17. Catania A, Lipton JM: The neuropeptide α- MSH: A key component in neuroimmunomo-dulation. Neuroimmunomodulation 1994;1:93-99.
18. Daynes RA, Robertson BA, Cho B-H, Bumam DK, Newton R: α-Melanocyte stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin-1-inducible responses in vivo and in vitro. J Immunol 1987;139:103-109.
19. Hiltz ME, Catania A, Lipton JM: α-MSH peptides inhibit acute inflammation induced in mice by rIL-lb, rIL-6, rTNFa and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 1992;4:320-328.
20. Martin LW, Catania A, Hiltz A, Lipton JM: Neuropeptide a-MSH antagonizes IL-6- and TNF-induced fever. Peptides 1991;12:297-299.
21. Ceriani G, Macaluso A, Catania A, Lipton JM: Central neurogenic antiinflammatory action of a-MSH: Modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 1994;59:138-143.
22. Murphy MT, Richards DB, Lipton JM: Antipyretic potency of centrally administred a-melanocyte stimulating hormone. Science 1983;221:192-193.
23. Mason MJ, van Epps D: Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by α-melanocyte-stimulating hormone. J Immunol 1989;142:1646-1651.
24. Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM: The neuropeptide a-MSH inhibits experimental arthritis in rats. Neuroimmunomo-dulation 1994;1:28-32.
25. Newbould BB: Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br J Pharmacol 1963;21:127-136.
26. Billingham MEJ: Models of arthritis and the search for anti-arthritic drugs; in Orme M (ed): Anti-Rheumatic Drugs. New York, Pergamon Press, 1990, pp 1-47.
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Muthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
28. Cassidy TJ, Levinson JE, Bass JC, Baum EJ, Brewer EJ, Fink CW, Hanson V, Jacobs JC, Masi AT, Shaller JG, Fries JF, McShane D, Young D: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1988;29:274-81.
29. Catania A, Suffredini AF, Lipton JM: α-MSH response to endotoxin in normal human subjects. FASEB J 1991;5:A1392.
30. Martin LW, Lipton JM: Acute phase response to endotoxin: Rise in plasma a-MSH and effects of a-MSH injection. Am J Physiol 1990;259:R768-R772.
31. Airaghi L, Lettino M, Manfredi MG, Lipton JM, Catania A: Cytokine antagonists in acute myocardial infarction. Third International Congress on the Immune Consequences of Trauma, Shock and Sepsis. Mechanisms and Therapeutic Approaches, 2-5 March 1994, Munich. Intensive Care Med 1994;20(suppl 1):S58.
32. Lipton JM, Macaluso A, Hiltz ME, Catania A: Central administration of the peptide α-MSH inhibits inflammation in the skin. Peptides 1991;12:795-798.
33. Holdeman M, Khorram O, Samson WK, Lipton JM: Fever specific changes in MSH and CRF concentrations. Am J Physiol 1985;248:R125-R129.
34. Bell RC, Lipton JM: Pulsatile release of antipy. retie neuropeptide a-MSH from septum of rabbit during fever. Am J Physiol 1987;252:R1152-R1157.
35. Mechanick JI, Levin N, Roberts JL, Autelitano DJ: Proopiomelanocortin gene expression in a distinct population of rat spleen and lung leukocytes. Endocrinology 1992;131:518-525.
36. Macaluso A, McCoy D, Ceriani G, Watanabc T, Biltz J, Catania A, Lipton JM: Antiinflammatory influences of α-MSH molecules: Central neurogenic and peripheral actions. J Neurosci 1994;14:2377-2382.
37. Levine JD, Collier DH, Basbaum AI, Moskowitz MA, Helms CA: Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 1985;12:406-411.
38. Levine JD, Goetzl EJ, Basbaum AI: Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polvar-thritidcs. Rheum Dis Clin North Am 1987;13:369-383.